105224-02-0 Usage
Uses
Used in Pharmaceutical and Agrochemical Industries:
(4-FLUORO-3-TRIFLUOROMETHYL-PHENYL)-HYDRAZINE is used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals. Its trifluoromethyl and fluorine-containing structure contributes to the improved bioavailability and metabolic stability of the final drug candidates, enhancing their therapeutic efficacy.
Used in Medical Imaging:
(4-FLUORO-3-TRIFLUOROMETHYL-PHENYL)-HYDRAZINE is utilized in the development of imaging agents and radiotracers for positron emission tomography (PET) and other medical imaging modalities. The presence of the fluorine atom allows for effective labeling and tracking of biological processes, aiding in the diagnosis and monitoring of diseases.
Used in Research and Development:
In the field of research and development, (4-FLUORO-3-TRIFLUOROMETHYL-PHENYL)-HYDRAZINE serves as a valuable compound for exploring new chemical reactions and synthetic pathways. Its unique structure allows chemists to investigate its reactivity and potential applications in various chemical transformations, leading to the discovery of novel compounds with potential uses in various industries.
Check Digit Verification of cas no
The CAS Registry Mumber 105224-02-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,5,2,2 and 4 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 105224-02:
(8*1)+(7*0)+(6*5)+(5*2)+(4*2)+(3*4)+(2*0)+(1*2)=70
70 % 10 = 0
So 105224-02-0 is a valid CAS Registry Number.
105224-02-0Relevant articles and documents
TRIAZOLONE COMPOUNDS AS mPGES-1 INHIBITORS
-
Page/Page column 124; 135; 136, (2014/01/08)
The present disclosure is directed to compounds of formula (I), and pharmaceutically acceptable salts thereof, as mPGES-1 inhibitors. These compounds are inhibitors of the microsomal prostaglandin E synthase-1 (mPGES-1) enzyme and are therefore useful in the treatment of pain and/or inflammation from a variety of diseases or conditions, such as asthma, osteoarthritis, rheumatoid arthritis, acute or chronic pain and neurodegenerative diseases.
Thrombopoietin Receptor Agonists
-
Page/Page column 31, (2010/11/30)
A compound of the formula (I) useful as promoters of thrombopoiesis and megakaryocytopoiesis, wherein A, B, D, E, W, X, Y, Z, R1 and R2 are defined as above.
